XJPX
4368
Market cap2.60bUSD
Jul 10, Last price
4,040.00JPY
1D
1.13%
1Q
32.46%
Jan 2017
60.89%
IPO
1,246.67%
Name
Fuso Chemical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1952 and headquartered in Osaka, Japan, Fuso Chemical Co.,Ltd. operates globally, specializing in the manufacturing and distribution of a diverse portfolio spanning life science, electronic material, and functional chemical products. The company's life science division offers a comprehensive array of organic acids and their derivatives, including malic, citric, L-tartaric, lactic, and gluconic acids, as well as ascorbic, isoascorbic acids, and amino acid compounds. This segment also provides industrial solutions such as water-soluble rust-preventive agents and grinding/cutting fluids. For the electronics industry, Fuso Chemical produces ultra-high purity colloidal silica and high-purity organosilica sol. Additionally, its functional chemical offerings encompass various oxidation-reduction agents and benzoic acid derivatives.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||